Canopy Growth Corporation (WEED) News

we see what I said many times ... the price is dripping steady until $2 - $3 ... there is nothing to stop it .... do you know what to do ?

Canopy Growth Polska Withdraws Popular Medical Cannabis Strain Penelope Due to Quality Concerns.

They want to re-start “fresh”.

Happyglass wants a quick Linton comeback.

He might just be the man for the job!!!

EAT !!!!!

if you are not a professional player ............. go away from this scam fast !

But not to worry!
Your shares are secured!!
Tilray has a PLAN!
They are buying alcool companies.
Smart…

They had a licence to grow and sell cannabis and they blew it…
No traction.
Users know better…
It’s called BC Bud.

I can assure you that large cannabis corporation folks do not consume cannabis. That would explain the mess they are in. Not knowing what to aim for. But that is ok. Every canna buyer knowns much better. And it’s called BC Bud! Ask for it bt name.
Large cannabis bunk producers will sell you cheap shares but.

This POS is really a POS huh? Haha. Just a train wreck of a company. Stoners shouldn't be running companies.

massive short ? ... I have not covered mine yet ,

Ponzi

laughing ....

Where is Bruce?

It's official. AC# has now surpassed this POS in price big time. Never thought I'd see that.

The company says the board is in the process of hiring a firm to avoid a bankruptcy ?

we are at a critical point .... the volume will be lower and lover every day , the price steady down --- I see a dead cat without hope

you cannot artificially maintain the price forever ...

Klein’s growing moldy bunk days are over…
Canopy Growth Announces CEO Succession Plan
Doomed
August 16, 2024


ImageCanopy Growth Announces CEO Succession Plan
Canopy Growth Announces CEO David Klein’s Retirement After Transformative Tenure, Search for New Leadership Begins as Company Focuses on Continued Growth and Profitability.
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced today that CEO David Klein will be retiring at the end of the company’s fiscal year on March 31, 2025. Until a successor is named, Klein will continue in his role, focusing on advancing Canopy Growth’s strategic objectives, including profitability, and ensuring a smooth transition for the incoming CEO. The Board has initiated a comprehensive search process to identify a candidate with the skills and experience needed to lead the company into its next phase of growth.

Klein, who joined Canopy Growth in January 2020, has been pivotal in transforming the company into a leaner, more focused organization🤣.

Under his leadership, Canopy Growth adopted an asset-light model in Canada and international markets, including Germany, and launched Canopy USA, giving shareholders unique exposure to the U.S. cannabis market ahead of federal legalization. His tenure is marked by the recent first-quarter results for fiscal year 2025, which showed a 67% increase in gross profit year-over-year and a consolidated gross margin of 35%, reflecting the company’s improved financial position.

Klein expressed his gratitude to the Canopy Growth team and shareholders, emphasizing his commitment to driving the company toward profitability in his remaining months. He stated that his experience at Canopy Growth has reinforced his belief in the power of cannabis to improve lives and that he is confident in the company’s future.

David Lazzarato, Chairman of the Board, praised Klein’s leadership, noting his instrumental role in the company’s transformation and the establishment of Canopy USA. The Board remains committed to appointing a new CEO who will continue to drive Crappy Growth’s ambitious vision, ensuring that the company remains a leader in the global cannabis market.

This leadership transition comes at a crucial time for Canopy Growth as it continues to strengthen its position in the competitive cannabis industry.😂

i do not think ... it will hold long ..

Canaccord Genuity has taken a more pessimistic stance by downgrading its target price for Canopy Growth to $3.5 from $5 and maintained a “Sell” rating. This significant reduction in target price suggests Canaccord Genuity’s concerns about the company’s near-term prospects and its ability to overcome industry challenges. The “Sell” rating indicates a belief that the stock may underperform relative to broader market expectations.

THE GLOBE AND MAIL
Cannabis firm Canopy Growth reports $127.1-million first-quarter loss, revenue down from year ago
Revenue for the first quarter of Canopy’s 2025 financial year totalled $75.8-million, down from $88.6-million in the same quarter last year
AUGUST 9, 2024
===============================
do you like it ? .... we witness an agony ,

I see desperation .... some caught people try to sell , idiots buy .... you still can make money on CGC playing daily but this is not for everybody ,

dead cat ... only can go down

Just realized a*b is now more than cgc in stock price. This isn't looking too good here

CGC is a joke ... it cuts a loss a bit ... only because its revenue is smaller

It is becoming increasingly clear that Mr. Klein has a real problem driving investor value. Everything from a reverse stock split to continuous quarterly reports missing projection and more alarmingly ongoing degradation in top line revenue. Equally alarming is that he apparently has not cracked the code to driving performance or value based results that bode well for investor confidence. He has to go and be replaced with a full on turn around CEO.

what to expect tomorrow after opening ? .... the loss will be huge in millions , after opening , the price will go up ( manipulations ) for a day or two and than ...
hold the handrail , back to $5/sh ..

Minus 0.01$

nice chart today :))))
hold handrails on Friday ... another day of big loss !

+0.30$

0.34$DOWN

And all of that comes amid a global market meltdown. Japan’s Nikkei 225 index nosedived 12% — its worst rout in history.
==================================================================================================

look for a handrails !

0.25$ DOWN.

0.25$ DOWN with a Government licence to grow and sell bunk weed.
Where is Bruce?

-0.25
They have a licence to sell weed but they simply cannot get it together.
Reminds me of a weird fat & yellow smelly guy who losing it completely.
Lol.
Suits.

0.29$ DOWN

CGC is expected to release earnings on August 9, 2024 before the market opens (BMO)
============================================================================
what does it mean " before the market opens " ? .... the answer is simple - very bad earning , CGC management hopes that there is not enough time for idiots to realise how bad the earning is ..... and for a while CGC can flow ...

Happyglass wants Linton to come back and save the day… Linton as been growing in his garage and he thinks that he is better at it now… we will see.

each daily chart is so ugly ! .... first class manipulation ,

it is so hard to watch at .... when smart foxes make tonnes of $ and at the same time ordinary people lose everything

Canopy Gwth: Stocks Overvalued by Analyst Consensus on TSX (WEED)
Globe Investor - AI-generated - The Globe and Mail - Sat Jul 20, 7:27PM CDT
Canopy Growth Corp is among the group of overvalued stocks on the Toronto Stock Exchange. This means the consensus value for each stock on this list is below its current price.

Based on 10.00 analysts, Canopy Growth Corp gets an average recommendation of "Moderate Sell" according to Zacks. From those 10 analysts, 1 have buy ratings, 5 have sell ratings and 4 analysts gave hold ratings.

this sick stock is good for everybody but .... idiots

I said the same thing here in 2016, just after patients won the legal right too grow cannabis on property, same year the stockmarket weed executives started collecting investors money and telling a tale on how rich they will make you. while these CEOs are extorting medical patients/growers with threats of arrest. Wish you listened?

RCMP went silent about massive pot bust over concern for marijuana producer’s stock price, documents reveal

There were also concerns the release of information could embarrass Health Canada and expose 'deficiencies' in new medical marijuana regulations

https://nationalpost.com/news/canada/rcmp-went-silent-about-massive-pot-bust-over-concern-for-marijuana-producers-stock-price-documents-reveal

This thing is a huge scam. All of these pot companies are. None of them make any money and never will. But they are all good at selling shares.

at each financial statement CGC management says the same .... " in order to achieve a profit we bla , bla, bla " ...............and no change ! this company is a joke

Canopy Growth Corporation Common Shares is estimated to report earnings on 08/14/2024. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.32. The reported EPS for the same quarter last year was $-0.4.
===========================================================================
so we will see another big loss of millions of $ ...

nice manipulation , good for idiots !

Buy before price come down…

Home / Cultivation
Judge keeps Alabama medical marijuana licensing on hold
By Doomed
July 8, 2024

An Alabama judge has extended a temporary restraining order on the issuance of medical marijuana business licenses in yet another delay to the market’s launch.

Montgomery County Circuit Judge James Anderson, according to the Alabama Reflector, also instructed the state’s Medical Cannabis Commission to begin investigative hearings requested by companies denied licenses in the previous round.

The restraining order was pushed by Alabama Always, an MMJ company seeking one of the state’s vertically integrated licenses.

Last December, Alabama regulators issued five integrated licenses to MMJ companies, including:

Flowerwood Medical Cannabis.
Specialty Medical Products of Alabama.
Sustainable Alabama.
Trulieve AL.
Wagon Trail Med-Serv.
The application and selection process for those integrated licenses sparked lawsuits after the state’s first two attempts to issue them.

A judge blocked a third round of MMJ licensing in January after noting “a serious question” as to whether it “is also invalid.”

Meanwhile, more than three years have passed since the governor signed into law the Alabama Compassionate Act, which allowed MMJ products for patients suffering from a host of chronic health issues.

do not forget ... price $8.64 means - 86 cents before reverse split , the end is coming sooner than you think ,

I do not see green lights.... even at the end of the tunnel